- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01613859
Measurement of Cardiac Output and Intravascular Volume Status in Children Using COstatus (SH)
May 25, 2016 updated by: Transonic Systems Inc.
Measurement of Cardiac Output and Intravascular Volume Status in Critically Ill Children Using an Ultrasound Dilution Method (COstatus)
Assessment and monitoring of cardiac function in the pediatric intensive care unit (PICU) is an integral part of hemodynamic monitoring of critically ill patients whether it is done directly or indirectly.
Measurement of cardiac output (CO) can specifically guide therapies to support the cardiovascular system in critically ill children with multi organ dysfunction.
Because of the side effects involved in measuring cardiac output directly, intensive monitoring of patients is currently limited to an integrated assessment of tissue perfusion, oxygen delivery and cellular health both at regional and global levels.
Currently available methods of measuring CO have their limitations and complications, and are not used routinely for bedside monitoring.
Therefore, the investigators propose to use a newly developed method, termed COstatus for the monitoring of CO in patients admitted to PICU.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
9
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32608
- Shands Children's Hospital, University of Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 21 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Pediatric Patients (under 21 years of age) in the ICU
Description
Inclusion Criteria:
- Patients under 21 years
- Presence of compensated or decompensated shock irrespective of etiology
- Presence of an existing peripheral arterial and central venous catheters
Exclusion Criteria:
1. Patients allergic to heparin
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparing CO and other clinical markers in Pediatric ICU
Time Frame: During patients stay in ICU with insitu catheter, expected average 3-4 days
|
The objective of this study is to see if the CO measurements obtained with COstatus show a linear correlation with all other indirect and invasive methods currently used to measure CO (within acceptable range) and with the CO measured by thermodilution in the cardiac catheterization lab.
|
During patients stay in ICU with insitu catheter, expected average 3-4 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jai Udassi, MD, Shands Children's Hospital, University of Florida
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
May 30, 2012
First Submitted That Met QC Criteria
June 4, 2012
First Posted (Estimate)
June 7, 2012
Study Record Updates
Last Update Posted (Estimate)
May 27, 2016
Last Update Submitted That Met QC Criteria
May 25, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- TSI-G-COstatus-12A-H
- R44HL061994 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intensive Care
-
Saint Savvas Anticancer HospitalUnknownPostoperative Care | Intensive CareGreece
-
University of MelbourneEnrolling by invitationICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care SyndromeAustralia
-
Seoul National University HospitalMinistry of Food and Drug Safety, KoreaCompletedPostoperative Care | Intensive Care UnitKorea, Republic of
-
Potrero MedicalCompletedCritical Care, Intensive Care
-
Cardiff and Vale University Health BoardCompletedIntensive CareUnited Kingdom
-
Vanderbilt UniversityCompleted
-
Medical University of GrazCompletedIntensive CareAustria
-
Chelsea and Westminster NHS Foundation TrustImperial College London; CW plusRecruiting
-
Centro Hospitalar de Vila Nova de Gaia/Espinho,...University of MinhoCompleted